• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONVATEC LTD AQUACEL AG+ EXTRA; DRESSING, WOUND, DRUG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONVATEC LTD AQUACEL AG+ EXTRA; DRESSING, WOUND, DRUG Back to Search Results
Model Number 413566
Device Problems Delivered as Unsterile Product (1421); Unsealed Device Packaging (1444); Device Damaged Prior to Use (2284); Packaging Problem (3007)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Manufacturer Narrative
Device 2 of 2 e1: (b)(6).Photo was reviewed.Discoloration was caused by oxidizing due to heat from sealing and product exposed to light.Based on the available information, this event is deemed to be a reportable malfunction.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number reporting site: 1049092 manufacturing site: 1000317571.
 
Event Description
The nurse reported that two dressings were in poor condition.At the time of opening the device to perform the cure, the product had a different color and where it was sealed, it affected the internal product.The products were not used.The photographs depicting the issue were received from the complainant.
 
Event Description
To date no additional patient or event details have been received.
 
Manufacturer Narrative
Additional information - this emdr is being submitted to include the below: h6 - investigation results under imdrf cause investigation code, imdrf investigation findings, imdrf cause conclusions.Aquacel ag+ extra 5x5cm (1x10pk)ster eur was manufactured under system application product (sap) code 1708330 and manufacturing lot number 2k03160 on 02 november 2022.Lot # 2k03160 was sterilized under run id 2163-3019a and released on review of results of sterilization provided by sterilization company steris.All of the results were within specification and products were released.No nonconformity was identified during the manufacturing process of lot 2k03160.This is the only complaint for the affected lot registered within database.Seven photographs were received for this issue and have been evaluated in accordance with work instruction (wi).The photographs confirm the product, lot and expected complaint issue where two open sachets are shown with the dressing trapped in the seal.A corrective action / preventive action (capa) was raised for previous complaints for dressing in seal, and an investigation completed.Investigation identified that the alteration of the top web print completed while the line was running resulted in dressing in seal.Operators were asked why it was necessary to alter the print, and it was identified operators would adjust print to reduce the number of print rejects.Access to alter the print web has since been restricted to engineer level, and it has been communicated that print position is only to be altered during batch set up and not during the machine running.The bounding for this previous corrective action / preventive action (capa) included all of the 5x5cm dressing sizes manufactured on doyen 3, including this batch.This batch is not listed within the corrective action / preventive action (capa) as there was no product remaining in dcs at the time of bounding.As improvements are being made as a result of the corrective action / preventive action (capa), no further corrective action / preventive action (capa) is required.The previous capa also had a health hazard evaluation (hhe) within record in database, identifying potential health hazards, so future complaints of this kind can be closed to the original corrective action / preventive action (capa) and health hazard evaluation (hhe).This issue will be monitored through the post market product monitoring review process, standard operating procedure (sop).To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number: reporting site: 1049092.Manufacturing site: 1000317571.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AQUACEL AG+ EXTRA
Type of Device
DRESSING, WOUND, DRUG
Manufacturer (Section D)
CONVATEC LTD
first avenue
deeside industrial park
deeside, flintshire CH5 2 NU
UK  CH5 2NU
Manufacturer (Section G)
CONVATEC LTD
first avenue
deeside industrial park
deeside, flintshire CH5 2 NU
UK   CH5 2NU
Manufacturer Contact
pamela meadows
7815 national service road
suite 600
greensboro, NC 
3365424679
MDR Report Key17709929
MDR Text Key322943911
Report Number1000317571-2023-00198
Device Sequence Number1
Product Code FRO
UDI-Device Identifier00768455132010
UDI-Public00768455132010
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 08/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/08/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number413566
Device Lot Number2K03160
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received09/26/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/02/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-